Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity

Michael M Galagudza1, Dmitry V Korolev1, Dmitry L Sonin1, Viktor N Postnov2, Garry V Papayan3, Ivan S Uskov1, Anastasia V Belozertseva1, Eugene V Shlyakhto11Institute of Experimental Medicine, VA. Almazov Federal Heart, Blood and Endocrinology Center, St-Petersburg, Russian Federation; 2Chemical Fac...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael M Galagudza, Dmitry V Korolev, Dmitry L Sonin, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/bba6c45bf6d24d23bf509a8974798753
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bba6c45bf6d24d23bf509a8974798753
record_format	dspace
spelling	oai:doaj.org-article:bba6c45bf6d24d23bf509a89747987532021-12-02T05:17:40ZTargeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity1176-91141178-2013https://doaj.org/article/bba6c45bf6d24d23bf509a89747987532010-03-01T00:00:00Zhttp://www.dovepress.com/targeted-drug-delivery-into-reversibly-injured-myocardium-with-silica--a4136https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Michael M Galagudza1, Dmitry V Korolev1, Dmitry L Sonin1, Viktor N Postnov2, Garry V Papayan3, Ivan S Uskov1, Anastasia V Belozertseva1, Eugene V Shlyakhto11Institute of Experimental Medicine, VA. Almazov Federal Heart, Blood and Endocrinology Center, St-Petersburg, Russian Federation; 2Chemical Faculty, St-Petersburg State University, St-Petersburg, Russian Federation;&nbsp; 3Department of Pathophysiology, IP. Pavlov State Medical University, St-Petersburg, Russian FederationAbstract: The clinical outcome of patients with ischemic heart disease can be significantly improved with the implementation of targeted drug delivery into the ischemic myocardium. In this paper, we present our original findings relevant to the problem of therapeutic heart targeting with use of nanoparticles. Experimental approaches included fabrication of carbon and silica nanoparticles, their characterization and surface modification. The acute hemodynamic effects of nanoparticle formulation as well as nanoparticle biodistribution were studied in male Wistar rats. Carbon and silica nanoparticles are non-toxic materials that can be used as carriers for heart-targeted drug delivery. Concepts of passive and active targeting can be applied to the development of targeted drug delivery to the ischemic myocardial cells. Provided that ischemic heart-targeted drug delivery can be proved to be safe and efficient, the results of this research may contribute to the development of new technologies in the pharmaceutical industry.Keywords: nanocarriers, targeted drug delivery, myocardial ischemia Michael M GalagudzaDmitry V KorolevDmitry L Soninet alDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2010, Iss default, Pp 231-237 (2010)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Michael M Galagudza Dmitry V Korolev Dmitry L Sonin et al Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
description	Michael M Galagudza1, Dmitry V Korolev1, Dmitry L Sonin1, Viktor N Postnov2, Garry V Papayan3, Ivan S Uskov1, Anastasia V Belozertseva1, Eugene V Shlyakhto11Institute of Experimental Medicine, VA. Almazov Federal Heart, Blood and Endocrinology Center, St-Petersburg, Russian Federation; 2Chemical Faculty, St-Petersburg State University, St-Petersburg, Russian Federation;&nbsp; 3Department of Pathophysiology, IP. Pavlov State Medical University, St-Petersburg, Russian FederationAbstract: The clinical outcome of patients with ischemic heart disease can be significantly improved with the implementation of targeted drug delivery into the ischemic myocardium. In this paper, we present our original findings relevant to the problem of therapeutic heart targeting with use of nanoparticles. Experimental approaches included fabrication of carbon and silica nanoparticles, their characterization and surface modification. The acute hemodynamic effects of nanoparticle formulation as well as nanoparticle biodistribution were studied in male Wistar rats. Carbon and silica nanoparticles are non-toxic materials that can be used as carriers for heart-targeted drug delivery. Concepts of passive and active targeting can be applied to the development of targeted drug delivery to the ischemic myocardial cells. Provided that ischemic heart-targeted drug delivery can be proved to be safe and efficient, the results of this research may contribute to the development of new technologies in the pharmaceutical industry.Keywords: nanocarriers, targeted drug delivery, myocardial ischemia
format	article
author	Michael M Galagudza Dmitry V Korolev Dmitry L Sonin et al
author_facet	Michael M Galagudza Dmitry V Korolev Dmitry L Sonin et al
author_sort	Michael M Galagudza
title	Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
title_short	Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
title_full	Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
title_fullStr	Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
title_full_unstemmed	Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
title_sort	targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&nbsp; natural biodistribution, and acute toxicity
publisher	Dove Medical Press
publishDate	2010
url	https://doaj.org/article/bba6c45bf6d24d23bf509a8974798753
work_keys_str_mv	AT michaelmgalagudza targeteddrugdeliveryintoreversiblyinjuredmyocardiumwithsilicananoparticlessurfacefunctionalizationampnbspnaturalbiodistributionandacutetoxicity AT dmitryvkorolev targeteddrugdeliveryintoreversiblyinjuredmyocardiumwithsilicananoparticlessurfacefunctionalizationampnbspnaturalbiodistributionandacutetoxicity AT dmitrylsonin targeteddrugdeliveryintoreversiblyinjuredmyocardiumwithsilicananoparticlessurfacefunctionalizationampnbspnaturalbiodistributionandacutetoxicity AT etal targeteddrugdeliveryintoreversiblyinjuredmyocardiumwithsilicananoparticlessurfacefunctionalizationampnbspnaturalbiodistributionandacutetoxicity
_version_	1718400494930493440

Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,&amp;nbsp; natural biodistribution, and acute toxicity

Ejemplares similares

Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,  natural biodistribution, and acute toxicity